Following Nature’s Rules
An article in Arizona Alumni Magazine, Winter 2023, by Paul Tumarkin features Teleport Pharmaceuticals role in developing new methods for treating degenerative neurological disease.
Robin Polt is co-inventor of a new drug technology that skirts the brain’s natural defenses to treat previously unreachable receptor targets, of use in combating neurological disorders.
/ Chris Richards photo
In clear, easy to understand language, the new class of drugs derived from the work of Robin Polt, and specific drug candidates being developed by Teleport Pharmaceuticals, LLC are discussed as a breakthrough development for neurologically degenerative diseases.
By using the body’s own naturally occurring glycopeptides as drugs delivered across the blood brain barrier neurological degeneration can be altered, and because the body naturally creates these peptides there are no alien byproducts created when broken down be and excreted from the body. This is unlike the nasty byproducts that can take a toll on the body non-naturally occurring drugs.